跳至主要内容
临床试验/NCT03492879
NCT03492879Unknown不适用

Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity

Prof. Ziv Ben-Ari MD0 个研究点目标入组 210 人开始时间: 2018年5月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
210
主要终点
Evaluating the liver fibrosis stage using Electrical Impedance Technology (EIT)

研究概览

简要总结

The aims of this study are to assess the performance of the non-invasive Electrical Impedance Technology (EIT) in evaluating the liver fibrosis stage in patients with chronic liver diseases, in comparisons with a liver biopsy and/or Shear wave elastography and Liver Ultrasonography.

The second aim is comparing between Liver Ultrasonography and Electrical Impedance Technology (EIT) to quantify the hepatic steatosis grade in patients with Non Alcoholic Fatty Liver Disease (NAFLD) .

详细描述

The study will include 210 patients with chronic liver diseases. Relevant clinical data such as sex, age, weight, height, alcohol intake, medical history and routine lab results will be collected.

The study will include three groups:

  1. Patients with indication for liver biopsy will undergo a routine liver biopsy and also routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT) (70 patients).
  2. Patients with chronic liver diseases will undergo routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT) (70 patients).
  3. Patients with Non Alcoholic Fatty Liver Disease will undergo routine liver Ultrasonography, Shear wave elastography and quantification of liver steatosis using the Electrical Impedance Technology (EIT) (70 patients).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with chronic liver diseases

排除标准

  • Patients who don't have chronic liver diseases

研究组 & 干预措施

Biopsy: Routine tests & EIT Technology

Experimental

The patients will undergo a routine liver biopsy and also routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT).

干预措施: EIT Technology (Device)

Routine tests & EIT Technology

Experimental

The patients will undergo a routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT).

干预措施: EIT Technology (Device)

NASH : Routine tests & EIT Technology

Experimental

The patients will undergo a routine liver Ultrasonography, Shear wave elastography and quantification of liver steatosis using the Electrical Impedance Technology (EIT).

干预措施: EIT Technology (Device)

结局指标

主要结局

Evaluating the liver fibrosis stage using Electrical Impedance Technology (EIT)

时间窗: Each technology will be performed once in 1 year

Comparing EIT fibrosis stage result to fibrosis stage result of validated thechnologies

次要结局

未报告次要终点

研究者

发起方
Prof. Ziv Ben-Ari MD
申办方类型
Other Gov
责任方
Sponsor Investigator
主要研究者

Prof. Ziv Ben-Ari MD

Head of liver diseases center

Sheba Medical Center

相似试验

Non Invasive Electrical Impedance Technology (EIT)... | 临床试验